CN107050010A - Application of the Cichoric acid in the medicine of anti respiratory syncytial virus is prepared - Google Patents
Application of the Cichoric acid in the medicine of anti respiratory syncytial virus is prepared Download PDFInfo
- Publication number
- CN107050010A CN107050010A CN201710121616.8A CN201710121616A CN107050010A CN 107050010 A CN107050010 A CN 107050010A CN 201710121616 A CN201710121616 A CN 201710121616A CN 107050010 A CN107050010 A CN 107050010A
- Authority
- CN
- China
- Prior art keywords
- medicine
- echinacea
- virus
- cichoric acid
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Abstract
The invention discloses the new application of Cichoric acid --- the application in the medicine of anti respiratory syncytial virus is prepared.The present inventor screens using Chemistry for Chinese Traditional Medicine method to the antiviral ingredients in plant Echinacea, and optimal antiviral activity composition is found that by extracorporeal antivirus effect effect experiment --- Cichoric acid, and find that Cichoric acid is most strong to the Anti-viral activity in vitro of Respiratory Syncytial Virus(RSV) (RSV), better than comparison medicine Ribavirin, therefore, the medicine for preparing anti respiratory syncytial virus can be used for by active component of Cichoric acid, during concrete application, acceptable matrix or auxiliary material in pharmacy can be added in right amount, can also be with appropriate Drug combination.
Description
Technical field
The present invention relates to application of the Cichoric acid in the medicine of anti respiratory syncytial virus is prepared.
Background technology
Echinacea also known as Echinacea, purple coneflower, are herbaceos perennial, composite family Echinacea.Eighties of last century 70 years
Generation, Echinacea introduces China, is cultivated as ornamental plant;The nineties, Xiao Peigen academician first adjusts Echinacea as immune
Section agent makes referrals to the country, and domestic various regions start to introduce a fine variety as medicinal plant, and gradually puts into GAP standardized productions, so that
Ensure the materials safety problem of research and development.The existing several Echinacea preparations of recent year are developed and are applied to face
Bed, such as " golden screen capsule " (Zhejiang Zhengda Qingchunbao Pharmaceutical Co., Ltd), " purple sealwort " (limited public affairs of Chengdu Diao Pharmaceutical Group
Department) etc., it is the compound preparation of Echinacea and the qi-invigorating herb Radix Astragali.
Widely, main application is improved immunity of organism level, anti-inflammatory, scavenging activated oxygen with anti-for the application of Echinacea
Oxidation, antitumor, antiviral etc..Foreign countries are in the research of Echinacea antivirus action, Wacker is trained using mouse L-929 cells
Foster method confirms that Echinacea Purpurea Herb P.E can indirectly suppress the activity of influenza virus, herpesviral and vesicular stomatitis virus;
May has found that the water extract of Echinacea purpurea can substantially suppress influenza virus, herpesviral and poliovirus activity.At present,
The domestic research to Echinacea antivirus action is also in the starting stage, and document report focuses mostly in animal husbandry.Feng Shanxiang is investigated
Protective effect of the Echinacea compound to infection newcastle disease virus chick, artificial challenge infectious bursa of Fabricius virus chick,
And point out that Echinacea compound can be used for newcastle disease, the prevention and treatment of infections chicken cloacal bursa.On a cellular level, it is purple
Cone chrysanthemum compound preparation has obvious inhibitory action to NDV, and effect is better than Echinacea.
In the antiviral study of Echinacea, its extract infected by influenza, Coxsackie virus B, blister sore is had proven to
Cytopathy caused by poison, HSV- II has different degrees of inhibitory action, to Ard3、Ard7, parainfluenza virus, ECHO11And
The experiment in vitro of the grades of HSV- I is then without positive effect.Current China is also confined to stimulate to the research for introducing a fine variety Echinacea pharmacological activity
In terms of immune level, people is with anti-virus formulation not yet full-scale development.Echinacea is used for controlling for human viral disease realizing
During treatment, the problems such as still having unknown medicinal material shortage of standard, antiviral activity composition, antivirus action mechanism and unclear target spot
Lie across at the moment.Therefore it is that it obtains full-scale development in China to carry out total quality evaluation study and pharmacology activity research to Echinacea
The premise of application.
Echinacea is used as a kind of good Immune enhancement herbal medicine, its chemical composition and the existing more report of Ingredients Active.Mesh
It is preceding in the chemical composition and structural research of genus echinacea plant and its preparation, it is separated go out Caffeic acids derivative, alkyl acyl
Amine, polysaccharide, volatile oil, alkaloid, flavones, polyacetylene and other class chemical compositions etc..Cichoric acid is pole in Echinacea
For one of important immune active ingredient, pharmacological research in recent years shows, there is Cichoric acid enhancing immunologic function and anti-inflammatory to make
With, and hyaluronidase can be suppressed, protect the influence of free radical of the collagen from degraded can be caused.In the prior art not yet
See the relevant report in terms of anti respiratory syncytial virus on Cichoric acid.
The content of the invention
For above-mentioned prior art, the present invention is through research, it was found that the new application of Cichoric acid --- preparing preventing respiratory
Application in the medicine of syncytial virus.
The present invention is achieved by the following technical solutions:
The present inventor screens using Chemistry for Chinese Traditional Medicine method to the antiviral ingredients in plant Echinacea, and leads to
Cross extracorporeal antivirus effect effect experiment and be found that optimal antiviral activity composition --- Cichoric acid, and find that Cichoric acid is closed to respiratory tract
The Anti-viral activity in vitro of cellular virus (RSV) is most strong, better than comparison medicine Ribavirin, therefore, it can using Cichoric acid as activity into
Point be used to prepare the medicine of anti respiratory syncytial virus, during concrete application, can add in right amount in pharmacy acceptable matrix or
Auxiliary material, can also be with appropriate Drug combination.
Echinacea pharmaceutical active complicated component, have Caffeic acids derivative, alkylamide, polysaccharide, volatile oil,
Alkaloid, flavones, polyacetylene and other class chemical compositions etc., the present invention are not only found that Echinacea Purpurea Herb P.E to respiratory syncystial
Virus has inhibitory action, it is also expressly that Cichoric acid is the active ingredient of external anti respiratory syncytial virus, to the disease-resistant of Echinacea
Malicious research, the further research of Echinacea prescribed preparation etc. are significant.
Brief description of the drawings
Fig. 1::Normal cell and viral sick cell, wherein, A:Normal VERO cells (4 × 40);B:The virosis of HSV- I
Become (4 × 10);C:Normal VERO cells (4 × 10);D:RSV virus lesions (4 × 10);E:Normal RD cells (4 × 10);F:
EV71 virus lesions (4 × 10).
Fig. 2:The selection result block diagram of Echinacea extracorporeal antivirus effect spectrum.
Fig. 3:Echinacea modifiedly extracted method result block diagram.
Fig. 4:The antiviral result block diagram of Echinacea water extract D101 type macroreticular resin eluates.
Fig. 5:D101 macroreticular resin post separation sample Ps AD monitoring figures.
Fig. 6:D101 macroreticular resin post separation active component liquid chromatograms.
Fig. 7:Quick prepare compound efficient liquid phase detection chromatogram.
Fig. 8:Cichoric acid reference substance cleaved fragment information.
Fig. 9:Prepare sterling compound cleaved fragment information.
Figure 10:Echinacea prepares sterling Antiviral breeding result block diagram.
Embodiment
With reference to embodiment, the present invention is further illustrated.
Involved instrument, reagent, material etc. in following embodiments, are existing in the prior art unless otherwise noted
Conventional instrument, reagent, material etc., can be obtained by regular commercial sources.Involved experimental method in following embodiments, inspection
Survey method etc., is existing normal experiment method in the prior art, detection method etc. unless otherwise noted.
Test the screening of Echinacea extracorporeal antivirus effect spectrum
1. laboratory apparatus and material
1.1 medicine Echinacea dry aerial parts medicinal materials are purchased from Anhui Province Tongcheng City Wei Qing medicinal plants Co., Ltd, powder
Broken machine is crushed, standby;(Qilu Pharmaceutical Co., Ltd., specification is 50mg/mL, lot number to ribavirin injection:1501166141).
(VERO is HSV- I, RSV sensitive cells strain, by Shandong Province's medical science to 1.2 cell African green monkey kidney cells
Microbiological Lab of institute preserves);(the sensitive cells strain that RD is EV71, by the micro- life of Shandong Academy of Medical Sciences of rhabdomyoma cell
Thing laboratory is preserved).
1.3 viral seed culture of viruses HSV- I:F plants, quoted from microbiology teaching and research room of Shandong Medical University, cured by Shandong Province within 1996
Microbiological Lab of subject institute preserves;RSV:Long plants, in October, 2000 is quoted from Virology Inst., China Academy of Preventive Medicine Sciences's poison
Room is planted, this section office preserves;EV71, is isolated from Jinan Children's Hospital ICU wards and dies of illness infant (Genbank registration numbers:
HQ825317)。
1.4 reagent n-butanols, petroleum ether, ethyl acetate, acetone, ethanol, dimethyl sulfoxide (DMSO) (Tianjin richness space fine chemistry industry
Co., Ltd's product, is that analysis is pure);Cell culture fluid (1640 cell culture fluids, GIBCO products, containing 11% NBCS
And 100U/mL penicillin and streptomysin, put 4 DEG C it is standby);Cell maintenance medium (1640 cell culture fluids, GIBCO products, containing 2%
NBCS and 100U/mL penicillin and streptomysin);PBS (pH7.2,8g containing NaCl, KCl 0.2g, KH2PO40.2g、
Na2HPO42.9g, plus distilled water, to 1000mL, filtration sterilization, 4 DEG C of separating device is standby);Cell dissociation buffer (0.25% pancreatin,
Macgene Products, dispense to penicillin bottle, put -20 DEG C of refrigerators standby).
1.5 instrument CO2Constant incubator (SANYO GS Products);(Jinan Xin Beixi companies produce Biohazard Safety Equipment
Product);Superclean bench (Jinan Long Hong cleaning equipments Co., Ltd);High-pressure sterilizing pot (Shanghai Bo Xun Industrial Co., Ltd.s medical treatment
Instrument factory);Double two-sided clean work station (Suzhou purifying apparatus factory);Inverted microscope (Olympus Products);It is desk-top from
Dynamic balancing centrifuge (Changsha Xiang Zhi centrifuges Co., Ltd);Centrifuge (congratulates the desk-top refrigerated centrifuges of Li Shi);Ultra low temperature freezer
(- 80 DEG C, 725 types, ThermoForma companies);Low temperature refrigerator (- 40 DEG C, SANYO GS company;- 20 DEG C, the U.S. water chestnut of middle section is public
Take charge of product;4 DEG C, brother company of Haier product);Liquid nitrogen container (Sichuan liquid nitrogen tank farms product);96 porocyte culture plates (the U.S.
GIBCO Products);Degerming syringe needle filter (Solution of U.S. Pall Corporation, aperture:0.22 μm, diameter
13mm);Pipettor (German Eppendorf products, model:20-200μl;100-1000μl);Suction pipette head (Germany
Eppendorf products, supporting with pipettor);Sonic oscillation cleaning device (Kunshan Ultrasonic Instruments Co., Ltd.);The omnipotent powder of high speed
Broken machine (Beijing forever bright Medical Instruments Co., Ltd, FW-100);Water-bath (establishing instrument and meter Co., Ltd in Shanghai) electricity
Hot blast drying box (Tianjin Lai Boterui experimental instruments and equipment limiteds, GFL-230).
2. experimental method
2.1 prepare opposed polarity solvent Echinacea Purpurea Herb P.E
Echinacea medicinal powder 40g is taken, the distilled water for adding 8 times of amounts carries out decoction 2h, suction filtration;The dregs of a decoction after filtering are taken to add together
Sample amount distilled water continues to decoct 2h, suction filtration;Filtrate it will merge twice, water-bath is volatilized.Change respectively 80% ethanol, 100% ethanol,
Petroleum ether, ethyl acetate, n-butanol repeat above-mentioned processing step, prepare Echinacea opposed polarity extractive part.Water extract with
Cell maintenance medium is dissolved, and other extracts are dissolved with DMSO, and 0.22 μm of filter filtration sterilization is standby.
Take Echinacea powder 40g, plus 8 times of amounts 50% acetone ultrasonic extraction 1h, suction filtration, filter residue adds 8 times of amounts 50% the third again
Ketone repeats ultrasound 1h, suction filtration;Filtrate merges twice, and water-bath is volatilized, and dissolves appropriate with DMSO, 0.22 μm of filter filtration sterilization is standby
With.
2.2 opposed polarity solvent Echinacea Purpurea Herb P.E antiviral study in vitro
2.2.1 the recovery and passage of cell
Vero, RD cell frozen is taken out from liquid nitrogen, is invested in 37 DEG C of warm water and rocks rapidly, it is rapid in 1min
Thaw.800rpm centrifuges 5min, and cell is suspended, is transferred to containing cell culture fluid by abandoning supernatant using cell culture fluid
Tissue Culture Flask in, 37 DEG C, 5%CO2Static gas wave refrigerator in incubator.Cell grows up to individual layer after 2d, and 0.25% pancreatin digests simultaneously
1:2 passages, can be used for testing when growing up to individual layer to cell.
2.2.2 the amplification of virus
The above-mentioned long cell to individual layer is taken, abandoning supernatant will deposit in HSV- I, RSV, EV71 under the conditions of -80 DEG C
Virus is inoculated on corresponding sensitive cells respectively after thawing.In 35 DEG C, 5%CO2Under the conditions of incubator in be incubated 1h, take out
Add after cell maintenance medium, continue to place and cultivated in incubator.Day by day Microscopic observation cytopathy (cytopathic
Effect, CPE), when CPE reaches 90%, in ultra low temperature freezer multigelation 3 times, piping and druming centrifugation (20000r/min, 15min),
Take supernatant to dispense, carry out mark, -40 DEG C of refrigerators freeze standby.
2.2.3 the measure of virus virulence
Herpes simplex virus Ⅰ liquid, Respiratory Syncytial Virus(RSV) liquid are done 10 multiple proportions and is serially diluted with cell maintenance medium, laterally
Be seeded in 96 orifice plates and grow up on the vero cells of individual layer successively, longitudinal direction repeats 3 holes, while set normal cell controls, put 35 DEG C,
Cultivated in 5%CO2 incubators;Take EV71 virus liquids to do after the dilution of ten multiple proportions systems with same method, plant thin in the RD for growing up to individual layer
On born of the same parents.Observed after 48h under inverted microscope, lesion occurs in cell, be considered as viral virulence, terminated culture, observe and record cell
Lesion rate.
With Reed-Muench Liang Shi methods, i.e. formula (1), (2), each viral half cell infection amount TCID is calculated50
(50%tissue culture infective dose).
Formula (2) TCID50=Anti log (logC+pd × logCm)
Wherein:Pd=cells ratio away from;P1=is higher than 50% lesion percentage;P2=is less than 50% lesion percentage;C=is high
In the dilution factor of 50% lesion rate;Cm=doubling dilution coefficients.
2.2.4 the measure of drug cytotoxicity
Take under 2.1 standby opposed polarity extract appropriate, 2 multiple proportions made of cell maintenance medium and are serially diluted, totally 12 it is dilute
Degree of releasing, is loaded onto in 96 orifice plates and has grown up on vero, RD cell of individual layer respectively, each dilution factor longitudinal direction 3 holes of repetition, 37 DEG C,
Cultivated in 5%CO2 incubators.Micro- Microscopic observation lesion situation after 24 hours, treats that virus control lesion rate reaches 90%, termination
Culture, observes and records cytopathy (CPE) percentage of every kind of extract, and medicine half is calculated using Reed-Muench methods
Number poisoning concentration (TC50), and determine maximal non-toxic concentration (TC0)。
2.2.5 the influence that medicine is acted on pathological changes caused by virus
Opposed polarity extract standby under 2.1 is taken to make 2 multiple proportions series, dilution totally 12 dilutions of cell maintenance medium
Degree, is loaded onto on individual layer RD, VERO cell in 96 orifice plates successively by 100 μ L/ holes respectively, and each dilution factor repeats 3 holes, if sharp
Ba Weilin parenteral solutions stoste is positive control, and sets cell controls, virus control.Except cell controls plus 100 μ L cell maintenance mediums
Outside, each hole adds measures TCID under 2.2.350The μ L of virus liquid 100 of concentration.Put 35 DEG C, cultivate in 5%CO2 incubators, it is daily aobvious
Micro- Microscopic observation cytopathy, culture is terminated after 90% cytopathy occurs in virus control.Its CPE of Microscopic observation.Using
Reed-Muench methods calculate medicine medium effective concentration (EC50) (concentration for 50%of maximal
effect,EC50).According to the medicine median toxic concentration (TC under 2.2.450) and medicine medium effective concentration (EC50), calculate
The malicious index (TI) of the suppression of medicine.
Formula (3) ... TC50=[Anti log (log is higher than 50% lesion rate drug dilution angle value-pd)] × initial concentration
It is EC50 that cell survival rate, which is more than 50% last concentration,
Formula (4) ... EC50=[Anti log (log is higher than 50% survival rate drug dilution angle value-pd)] × initial concentration
3 experimental results
The result that 3.1 virus virulences are determined
The lesion situation of cell caused by observation virus, the types of HSV- I viral (F plants) are calculated by ReedMuench methods
TCID50=10-3.33The TCID of/100 μ l, RSV Strain50For 10-2.50The TCID of/100 μ l, EV71 Strain50For 10-4.33/
100μl。
Inhibitory action result of 3.2 medicines to virus
As a result it is as shown in Figure 1.By the CPE percentage of record, calculate medicine half using Reed-Muench methods and be poisoned
Concentration (TC50) and medicine medium effective concentration (EC50), and determine to press down malicious index (TI=TC50/EC50).It the results are shown in Table 1, Fig. 2.
The selection result of the Echinacea extracorporeal antivirus effect of table 1 spectrum
Note:- representing invalid, TI values are considered as effectively more than 4.
4. discuss
This experiment has investigated effect of the Echinacea opposed polarity position to HSV- I, RSV, EV71 institute cytopathogenic effect simultaneously,
Make the result of antiviral spectrum more accurate comprehensive.As a result show, Echinacea difference extract is to thin caused by HSV- I, RSV, EV71
Born of the same parents' lesion has different degrees of inhibitory action.By detecting that Echinacea opposed polarity extract resists to HSV- I, RSV, EV71
Virus effectiveness finds that 80% alcohol reflux, decocting boil position has preferable inhibitory activity to three kinds of viruses.By relatively each more effective
TI values find, 80% alcohol reflux position is boiled suppression of the position to HSV, RSV, EV71 to RSV, EV71 inhibition, decocting and imitated
Fruit is all higher than the antiviral effect of positive control drug Ribavirin.The purpose of this problem be find Echinacea it is antiviral effectively into
Point, and decocting boil position confrontation RSV best results (TI values have reached 196, much larger than positive control 31), therefore selection purple
Chrysanthemum water position is bored to RSV effect as tracking foundation, subsequent experimental direction is used as.
Test the optimization of two Echinacea extracting methods
Position is boiled in the decocting of clear and definite Echinacea in experiment one has more preferably to RSV institute's cytopathogenic effects than other polar fractions
Inhibition, therefore water extraction on the basis of optimize to determine a more preferable extraction scheme.
Because the main purpose of this research is qualitative, therefore only select to influence extraction effect larger temperature as investigation
Factor, sets water boiling and extraction and two kinds of extracting methods of water ultrasonic extraction respectively, and temperature factor is investigated to extracting by experiment in vitro
The influence of effect, so that it is determined that optimum extraction scheme.
1 laboratory apparatus and material
1.1 medicine Echinacea dry aerial parts medicinal materials are purchased from Anhui Province Tongcheng City Wei Qing medicinal plants Co., Ltd, powder
Broken machine is crushed, standby;Ribavirin injection (Qilu Pharmaceutical Co., Ltd., specification is 50mg/mL, lot number 1501166141).
(VERO, RSV the sensitive cells strain, by Shandong Academy of Medical Sciences microorganism of 1.2 cell African green monkey kidney cells
Laboratory is preserved.
1.3 viral seed culture of viruses RSV:Long plants, in October, 2000 quoted from Virology Inst., China Academy of Preventive Medicine Sciences's seed culture of viruses room,
This section office preserves.
1.4 reagent distilled water;Cell culture fluid (1640 cell culture fluids, GIBCO products, containing 11% NBCS and
100U/mL penicillin and streptomysin, put 4 DEG C it is standby);(1640 cell culture fluids, GIBCO products are new containing 2% for cell maintenance medium
Raw cow's serum and 100U/mL penicillin and streptomysin);PBS (pH7.2,8g containing NaCl, KCl 0.2g, KH2PO4 0.2g、
Na2HPO42.9g, plus distilled water, to 1000mL, filtration sterilization, 4 DEG C of separating device is standby);Cell dissociation buffer (0.25% pancreatin,
Macgene Products, dispense to penicillin bottle, put -20 DEG C of refrigerators standby).
1.5 instruments are with experiment one.
2. experimental method
The extraction of 2.1 opposed polarity Echinacea Purpurea Herb P.Es
(1) water ultrasonic extraction takes Echinacea powder 40g, plus 8 times of distilled water ultrasonic extraction 2h measured, suction filtration;Filter residue is again
Plus 8 times of amount distilled water repeat to extract, suction filtration;Filtrate merges twice, and 100 DEG C of water-baths are volatilized, and cell maintenance medium dissolving is appropriate, and 0.22
μm filter filtration sterilization, it is standby.
(2) water boiling and extraction method takes Echinacea medicinal powder 40g, and the distilled water for adding 8 times of amounts carries out decoction 2h, suction filtration;
The dregs of a decoction plus same amount distilled water after filtering is taken to continue to decoct 2h, suction filtration;Filtrate it will merge twice, water-bath is volatilized.Maintained with cell
Liquid dissolving is appropriate, and 0.22 μm of filter filtration sterilization is standby.
2.2 antiviral study in vitro
2.2.1 the measure of drug cytotoxicity
Take Echinacea water sonicated extract, water boiling and extraction thing appropriate, 2 multiple proportions are made of cell maintenance medium and are serially diluted, altogether
12 dilution factors, are loaded onto on the vero cells for having grown up to individual layer in porous plate, and each dilution factor repeats 3 holes, in 37 DEG C,
5%CO2Cultivated in incubator.Micro- Microscopic observation lesion situation after 24 hours, treats that virus control lesion rate reaches 90%, termination
Culture, is observed and records cytopathy (CPE) percentage, and medicine median toxic concentration is calculated using Reed-Muench methods
(TC50), and determine maximal non-toxic concentration (TC0)。
2.2.2 the influence that medicine is acted on pathological changes caused by virus
Take Echinacea water boiling and extraction thing, water sonicated extract to make 2 multiple proportions of cell maintenance medium and be serially diluted, totally 12 it is dilute
Degree of releasing, is sequentially added on the individual layer vero cells in 96 orifice plates in (100 μ L/ holes), and each dilution factor repeats 3 holes, if Ribavirin
Parenteral solution stoste is positive control, and sets cell controls, virus control.In addition to cell controls plus 100 μ L maintaining liquids, each hole adds
100 TCID50 viral 100 μ L.Put 35 DEG C, 5%CO2Cultivated in incubator, daily micro- Microscopic observation cytopathy is treated
Virus control occurs terminating culture after 90% cytopathy.Microscopic observation simultaneously records its CPE.Using Reed-Muench method meters
Calculate medicine medium effective concentration (EC50) (concentration for 50%of maximal effect, EC50).According to upper
State medicine median toxic concentration (TC50) and medicine medium effective concentration (EC50), calculate the malicious index (TI) of medicine suppression.
3 experimental results (are shown in Table 2, Fig. 3).
The Echinacea modifiedly extracted method result of table 2
4. discuss
Temperature can influence the dissolution efficiency by thermal lability composition, two in experiment kind extracting method mainly investigate temperature because
Influence of the element to active component extraction efficiency.This experimental result shows that the malicious index of suppression of water boiling and extraction is more than water ultrasonic extraction
The malicious index of suppression, while the effect of water extract is much larger than the effect of positive control drug Ribavirin.It follows that:Suppress
The active ingredient of RSV institutes cytopathogenic effect still has presence in a heated condition, and hot conditions are conducive to its dissolution, it is thus determined that
Water boiling and extraction method is final extracting method.
Test the isolation and purification of three Echinacea antivirus effective positions
The application of macroporous absorbent resin appears in nineteen sixties, is the another separation after ion-exchange
Purification process, the seventies start isolating and purifying applied to Chinese medicine.Macroporous absorbent resin passes through intermolecular force, hydrogen bond
The molecular sieve effect of suction-operated and loose structure plays a role, and material to be separated exists because of the difference of absorption affinity and molecular size range
The purpose of isolation and purification is reached in elution process.It is different with selected monomer molecule structure by its polarity size, it can be divided into
Nonpolar, middle polarity and polarity three types, preferable separating effect is respectively provided with to the medicine of various opposed polarities.D101 types are big
Macroporous adsorbent resin is the nonpolar EVA of the dilute type of benzene second, is a kind of artificial synthesized Polymer adsorption of porous spongy structure
Agent, the scope of application compares a wider spectrum.
The water soluble part of Echinacea is mainly the big polar substances such as Caffeic acids derivative, polysaccharide, protein, composition
Species is various and polarity is close, and separating difficulty is larger.Existing document report, caffeic acid derivative class is the important stimulation of Echinacea
The active component of immunity of organisms, in the case where intending as target components, selects D101 type macroporous absorbent resins, can be by
Big polar component is quickly eluted, and accomplishes that active principle loses less, and comparatively ideal purpose is isolated and purified so as to reach.
1 laboratory apparatus and material
Ethanol (Tianjin Fu Yu Fine Chemical Co., Ltd product is analyzed pure);D101 types macroporous absorbent resin (Cangzhou treasured grace
Chemical Co., Ltd.);Glass chromatography column (4.5 × 85cm of Φ).Remaining instrument is with material with experiment two.
2. experimental method
It is prepared by 2.1 sample solutions
Echinacea powder 50g is taken, the distilled water for adding 8 times of amounts carries out decoction 2h, suction filtration;Take the dregs of a decoction plus same amount after filtering
Distilled water continues to decoct 2h, suction filtration;Filtrate it will merge twice, 100 DEG C of water-baths are volatilized.Above-mentioned water boiling and extraction thing ultrasound is taken to be dissolved in
It is standby in 400ml water
The pretreatment of 2.2 macroreticular resins
A certain amount of D101 types macroporous absorbent resin is taken, 24h is soaked with 100% ethanol, the volume after being fully swelled is about
1L.The glass chromatography column (4.5 × 85cm of Φ) of cleaning is taken, wet method dress post is about at the 2/3 of pillar height, to use ethanol to resin height
It is rinsed.Detection post lower end trickle, i.e., press 1 by liquid and water at any time:5 mixing, if resulting solution clarification is saturating after mixing
When bright, distilled water flushing is used instead, the liquid flowed out into post stands resin column bed standby without ethanol flavor.
2.3 loading
Sample solution in 2.1 is splined in the macroporous resin column handled well with the slow drainage of glass bar, layer is opened
The valve of post lower end is analysed, allows sample solution slowly to flow, finally keeps liquid level to be higher by 2~3cm of resin column bed, closes valve,
Stand 12 hours.
2.4 elution
Successively gradient elution is carried out with water, 25% ethanol, 50% ethanol, 75% ethanol.Control the efflux rate of outflow about
For 1 drop/sec, one section is collected as per 200ml, each gradient is rushed to colourless and changes next gradient.Eluent is suitable by collecting
Sequence is numbered, and water bath method respectively, standby.
2.5 antiviral study in vitro
2.5.1 the measure of drug cytotoxicity
Take Echinacea macroreticular resin eluate appropriate, dissolved respectively with cell maintenance medium, and do 2 multiple proportions and be serially diluted, altogether
12 dilution factors, are loaded onto in 96 orifice plates and have grown up on the vero cells of individual layer, and each dilution factor longitudinally repeats 3 holes, in 37
DEG C, 5%CO2Cultivated in incubator.Micro- Microscopic observation lesion situation after 24 hours, treats that the lesion rate of virus control reaches
90%, culture is terminated, observes and records cytopathy (CPE) percentage, is calculated using Reed-Muench methods in medicine half
Malicious concentration (TC50)。
2.5.2 the influence that medicine is acted on pathological changes caused by virus
Take Echinacea macroreticular resin eluate to dissolve and make 2 multiple proportions of cell maintenance medium to be serially diluted, totally 12 dilution factors,
It is loaded onto successively on the individual layer vero cells in 96 orifice plates in (100 μ L/ holes), each dilution factor repeats 3 holes, if Ribavirin is injected
Liquid stoste is positive control, and sets cell controls, virus control.In addition to cell controls plus 100 μ L maintaining liquids, each hole adds 100
TCID50The μ L of RSV virus liquids 100.Put 35 DEG C, 5%CO2Cultivated in incubator, daily micro- Microscopic observation cytopathy treats disease
Poison control occurs terminating culture after 90% cytopathy.Microscopic observation simultaneously records its CPE.Calculated using Reed-Muench methods
Medicine medium effective concentration (EC50) (concentration for 50%of maximal effect, EC50).According to above-mentioned
Medicine median toxic concentration (TC50) and medicine medium effective concentration (EC50), calculate the malicious index (TI) of medicine suppression.
3 experimental results (are shown in Table 3, Fig. 4)
The antivirus action result of the Echinacea water extract D101 type macroreticular resin eluates of table 3
4. discuss
In elution process, to ensure that composition does not lose, initially outflow, also do not divided in equal volume by macroporous resin adsorption part
Section is collected;200ml is set during collection as a collection body, to ensure more preferable separating effect.Eluate serial number in table 3
After Antiviral breeding checking, the result in order merging the close collection section of adjacent ten effects.
Result is shown in chart, and water 2, water 3, water 4, water 5, the malicious index of suppression of water 6 separate pure more than D101 types macroreticular resin
The malicious index (TI=235) of suppression before change, and still better than Ribavirin (TI=32), illustrate to be made with D101 macroporous absorbent resins
Isolation and purification method for Echinacea water boiling and extraction thing is practical.
Make a general survey of the external anti respiratory syncytial virus result in this part to find, the antiviral effect at basic each elution position is excellent
In Ribavirin, there are two kinds of guesses for such case:1. richness of the isolation and purification method that this experiment is used to active component
Collect effect undesirable;2. there are a variety of anti respiratory syncytial virus active components in Echinacea, and strongly active composition is mainly concentrated
At the water position of big polarity.Which kind of guess no matter this experiment meet, and illustrates, other in addition to the effect preferably gone out concentrates position
Still there is the value of continual exploitation at elution position, very important.
Test analysis and the Structural Identification of the antiviral active ingredient of four Echinaceas
1 laboratory apparatus and material
1.1 medicines take three reclaimed waters 2 of experiment, water 3, water 4, water 5, water 6 to merge, 4000rpm centrifugation 15min, supernatant, precipitation
100 DEG C of water-baths are volatilized respectively, standby.
1.2 reagent alcohols, butyl acetate, formic acid, phosphoric acid (Tianjin Fu Yu Fine Chemical Co., Ltd product is analyzed pure);
Acetonitrile (TEDIA company, Yu Wang groups, chromatographically pure);
1.3 instrument PAD UV-detectors;High performance liquid chromatograph;The series of high efficiency liquid chromatographs of Agilent 1260
(Agilent company of the U.S., equipped with on-line degassing machine, quaternary pump, automatic sampler, column oven, PDAD);
Agilent 6230TOF mass spectrographs (Agilent company of the U.S., equipped with standard electric spray ion source, MassHunler Data
Acquisition, which works online, to stand and Qualiatise Analysis off-line analysis software);Pressed in CHEETAHTMMP100 fast
Speed purifying preparation system (Tianjin Bonaaijieer Technology Co., Ltd).Remaining same experiment three.
2. experimental method and result
The selection of 2.1 Detection wavelengths
Take and Supernatant samples are centrifuged in this experiment 1.1 in right amount, with distilled water diluting to close to colourless, through PAD UV-detectors
Full wavelength scanner, as a result such as Fig. 5.
As shown in Figure 5, PAD monitoring wave-length coverage is 200~500, a length of 330nm of maximum absorption wave of sample, by it
It is used as the reference conditions of application high-efficient liquid phase analysis.
2.2 high performance liquid chromatography detection
2.2.1 sample treatment, which takes, centrifuges Supernatant samples in right amount in this chapter, ultrasound is dissolved in ultra-pure water, 0.45 μm of miillpore filter
Filtration, obtains test sample, standby.
2.2.2 chromatographic condition
Consulting literatures simultaneously grope by Binding experiment, and the HPLC testing conditions for determining sample are:Syncronis C18 chromatographic columns
(250mm×4.6mm,5μm);35 DEG C of column temperature;Flow velocity 1ml/min;Detection wavelength 330nm;The μ l of sample size 20;Mobile phase condition second
The phosphoric acid solution (B)=10 (A) of nitrile (A) -0.3%:90 (B), isocratic elution.
2.2.3 HPLC testing results
It will be appreciated from fig. 6 that the separating resulting composition letter under 2.2.2 chromatographic conditions of the separating obtained sample of D101 macroporous absorbent resins
Single, separating degree is good, therefore it is refined that in half preparation solution this sample is mutually continued into purifying.
Combiflash companion condition is pressed in 2.3
This experiment uses SQ230020-0 Flash spherical AQC18 (spherical 20~35 μm, 20g) chromatographic column, fast in middle pressure
Speed is prepared in liquid phase, and mobile phase is used as using the phosphoric acid of acetonitrile -0.3%;Flow velocity:15ml/min;Column temperature:Room temperature;Collect wavelength:
325nm。
Table 4 quickly prepares the gradient of liquid phase
The preparation of 2.4 compounds
Weigh the Supernatant samples 0.0972g in 1.1, the ultrasonic dissolution in 1ml distilled water, sample introduction.By quick under 2.3
Chromatographic condition preparation is prepared, product is prepared by peak collection, and number.
Product will be prepared and cross 0.45 μm of miillpore filter respectively, by the chromatographic condition under 2.2.2, sample introduction high performance liquid chromatography
Detected, obtain unimodal material, see Fig. 7.
According to high performance liquid chromatography detection result, merge spectrogram same composition, 40 DEG C of waters bath with thermostatic control are volatilized, and obtain white needles
Crystallization.The Structural Identification of 2.5 compounds
Cichoric acid reference substance:ESI-MS:492.1135[M+H2O]+, molecular weight 374.1, molecular formula is C22H18O12.Cracking
Fragment when voltage is 100V:135.0431,163.0384,224.1249,295.0446,325.0710,391.2831,
492.1139,619.1109,767.1069,841.0523,922.0092,966.1917,1109.1847;Cracking voltage is
Cleaved fragment during 200V has:135.0441,163.0390,295.0454,378.9861,492.1132,569.0255,
691.0268,767.1098,841.0469,922.0094,966.1924,1109.1796.As shown in Figure 8.
Under same experimental conditions, the Dissociation fragment of gained sterling compound:When cracking voltage for 100V, fragment has:
163.0389,224.1273,295.0450,325.0694,391.2831,457.0759,492.1135,619.1061,
731.1020,841.0503,922.0093,966.1908,1111.1960;When cracking voltage for 200V, fragment has:
135.0441,163.0392,295.0469,378.9877,492.1126,619.1096,731.1036,841.0484,
922.0099,966.1929,1111.1909.As shown in Figure 9.Dissociation fragment with Cichoric acid reference substance is basically identical, therefore can sentence
Resulting white, needle-shaped crystals of breaking are Cichoric acid.
The pharmacy in vitro experiment of 3 sterling compounds
The measure of 3.1 drug cytotoxicities
Take preparation sterling, dissolved with cell maintenance medium, cross 0.45 μm of miillpore filter, do 2 multiple proportions and be serially diluted, totally 12 it is dilute
Degree of releasing, is loaded onto on the vero cells for having grown up to individual layer in porous plate, and each dilution factor repeats 3 holes, in 37 DEG C, 5%CO2Training
Support in case and cultivate.Micro- Microscopic observation lesion situation after 24 hours, treats that the lesion rate of virus control reaches 90%, terminates culture,
Observe and record cytopathy (CPE) percentage, medicine median toxic concentration (TC is calculated using Reed-Muench methods50)。
The influence that 3.2 medicines are acted on pathological changes caused by virus
Take the Supernatant samples in 1.1 and prepare sterling in right amount, dissolved with cell maintenance medium, cross 0.45 μm of miillpore filter, used
Cell maintenance medium, which dissolves and does 2 multiple proportions, to be serially diluted, and totally 12 dilution factors, are loaded onto the individual layer vero cells in 96 orifice plates successively
Upper (100 μ L/ holes), each dilution factor repeats 3 holes, if ribavirin injection stoste is positive control, and sets cell controls, disease
Poison control.In addition to cell controls plus 100 μ L maintaining liquids, each hole adds 100 TCID50The μ L of RSV virus liquids 100.Put 35 DEG C, 5%
Cultivated in CO2 incubators, daily micro- Microscopic observation cytopathy terminates training after 90% cytopathy occurs in virus control
Support.Microscopic observation simultaneously records its CPE.Medicine medium effective concentration (EC is calculated using Reed-Muench methods50)
(concentration for 50%of maximal effect, EC50).According to said medicine median toxic concentration (TC50)
And medicine medium effective concentration (EC50), calculate the malicious index (TI) of medicine suppression.
3.3 experimental results (as shown in table 5, Figure 10)
The Echinacea of table 5 prepares sterling Antiviral breeding result
4. discuss
Gained compound Cichoric acid is prepared in this experiment is to the inhibition index of Respiratory Syncytial Virus(RSV) institute cytopathogenic effect
4272, it is 9 times of supernatant before preparing, is 256 times of positive control drug, suppression toxic effect fruit is prominent, therefore is external preventing respiratory
The active ingredient of syncytial virus.
Fig. 4 in experiment three, water 2 that antiviral study in vitro preferably goes out, water 3, water 4, water 5, the position of water 6 it is disease-resistant
Toxic effect fruit difference is larger, because each position sample size is less, to be smoothed out subsequent experimental, the sample used in this experiment
For the consolidated material at each position.
Due to still there is the macromolecular substances such as polysaccharide, protein, tannin in macroreticular resin eluate, after this experiment is using centrifugation
The mode of supernatant is taken to remove big molecular impurity, to reduce purifying difficulty.
Sample finds that it is the 4th peak in gross sample that compound, which is made, with preparing the HPLC collection of illustrative plates of product before prepared by contrast,
Its content highest in gross sample, therefore be easier to get.
Summarize
This research is supplemented and the perfect character of three kinds of separate sources Echinaceas, microscopical characters data;Establish Echinacea
Extracorporeal antivirus effect spectrum;Followed the trail of by external pharmacological activity and be found that active component Cichoric acid.The Experiment Result of this research is purple
Accurate use for boring the antiviral further research of chrysanthemum and three kinds of separate sources Echinaceas provides science data and data.
This experiment in the screening operation of antiviral activity composition, take " screening scope by width to it is narrow, from the superficial to the deep,
The experimental program of progressively lock onto target ".The different type virus with different inhereditary materials is selected first, with reference to opposed polarity portion
Position extract does wide spectrum screening, and comprehensive analysis the selection result determines best results polar fraction and viral species, and then with effective
It is the separation at position, purifying, refined as tracking direction, using selected viral pharmacy in vitro as screening foundation, promote, enter layer by layer
And obtain antiviral active substance.
Current to trigger the treatment of disease to have no specific drug for Respiratory Syncytial Virus(RSV), Ribavirin is clinical conventional
Medicine.In this experiment, the positive control drug that Ribavirin is Antiviral breeding is selected, although its extracorporeal extracorporeal suppression is not protruded,
But can not negate its status in clinical practice.For ensure experimental result uniformity, should continue using Ribavirin as
The positive control drug for investigating Cichoric acid antiviral effect is applied to internal pharmacological evaluation, also it is contemplated that increasing other positive controls
Medicine.
Cichoric acid in Echinacea is labile element, and content is unstable in the preparation commodity of Echinacea or does not deposit for it
, therefore often it is used as quality standard using polysaccharide constituents or acid amides constituents in quality control.The display of this experimental result, Cichoric acid
The external RSV effects that suppress are protruded, and show that its pharmacological activity is affirmed, thus its content in curative drug can be to certain
The curative effect of a little diseases can produce certain influence.Therefore, one is entered in follow-up internal pharmacological evaluation, in Echinacea prescribed preparation
In step research, for the effective utilization and its action effect of Cichoric acid, further investigation can be also done.
Echinacea is used in the therapeutic process of human viral disease realizing, still has medicinal material shortage of standard, disease-resistant
Cytotoxic activity composition is unknown, antivirus action mechanism, lie across at the moment the problems such as target spot is unclear.Therefore pharmacological activity is carried out to Echinacea
It is the premise that it obtains further development and application in China to study, find reliable active component and carry out total quality evaluation.
Claims (1)
1. application of the Cichoric acid in the medicine of anti respiratory syncytial virus is prepared.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611056388 | 2016-11-24 | ||
CN2016110563882 | 2016-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107050010A true CN107050010A (en) | 2017-08-18 |
CN107050010B CN107050010B (en) | 2020-03-06 |
Family
ID=59621804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710121616.8A Active CN107050010B (en) | 2016-11-24 | 2017-03-02 | Application of chicoric acid in preparation of medicine for resisting respiratory syncytial virus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107050010B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113845422A (en) * | 2021-11-04 | 2021-12-28 | 山东中医药大学 | Process for preparing high-purity L-chicoric acid from echinacea purpurea in batches and application |
CN113908143A (en) * | 2021-10-25 | 2022-01-11 | 山东中医药大学 | Chicoric acid inhalation aerosol and preparation method and application thereof |
-
2017
- 2017-03-02 CN CN201710121616.8A patent/CN107050010B/en active Active
Non-Patent Citations (4)
Title |
---|
S.E.BINNS等: "Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I)", 《PLANTA MED》 * |
吴启林: "紫锥菊中菊苣酸提取纯化工艺研究", 《中国优秀博硕士学位论文数据库(硕士) 工程科技I辑》 * |
唐维等: "咖啡酸衍生物抗呼吸道合胞病毒活性研究", 《中国化学会第十届全国天然有机化学学术会议论文集》 * |
洪纪宪编著: "《神奇紫锥菊:21世纪咽喉炎感冒克星》", 31 May 2004, 中医古籍出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113908143A (en) * | 2021-10-25 | 2022-01-11 | 山东中医药大学 | Chicoric acid inhalation aerosol and preparation method and application thereof |
CN113845422A (en) * | 2021-11-04 | 2021-12-28 | 山东中医药大学 | Process for preparing high-purity L-chicoric acid from echinacea purpurea in batches and application |
CN113845422B (en) * | 2021-11-04 | 2024-01-30 | 山东中医药大学 | Process for preparing L-chicoric acid from Echinacea purpurea in batches and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN107050010B (en) | 2020-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103435580B (en) | Lingzhiol A and application of lingzhiol A in drug production and foods | |
CN110672747A (en) | Method for detecting epimedium component, method for identifying variety of epimedium and application | |
CN102058641A (en) | Angelica dahurica extract and quality detection method | |
CN104391072A (en) | Quality control method of traditional Chinese medicine compound preparation for treating osteoporosis | |
CN102058814B (en) | General flavone extractive of four medicaments including grassleaf sweetflag rhizome and preparation method thereof | |
CN107050010A (en) | Application of the Cichoric acid in the medicine of anti respiratory syncytial virus is prepared | |
CN101337060B (en) | Quality control method of Gongyankang grannule | |
CN107556325B (en) | The separation method of Alkaloid monomer in a kind of Diels Stephania Root | |
CN101195646B (en) | Production method of stilbene glycoside extract | |
CN101926889B (en) | Method for detecting white paeony root-medlar particles | |
CN107737201B (en) | Application of radix tetrastigme extract in resisting virus | |
CN101028322B (en) | Use of Maoliefengdou extract for preparing anti-cancer medicine | |
CN101766664B (en) | Detection method of total saponin of Radix Ilicis Asprellae | |
CN1989984B (en) | Chuanxiong rhizome effective ingredient, preparing method, preparation and use thereof | |
CN102048770B (en) | Artificially-cultured cordceps militaris sporocarp extract and preparation process thereof | |
CN104491048B (en) | A kind of loquat leaf total sesquiterpene glucoside extract and preparation method and application | |
CN106491670A (en) | A kind of Fructus Bruceae extract, extracting method and application | |
CN105348364B (en) | Method for extraction of oleanolic acid from fructus ligustri lucidi | |
CN105806964A (en) | Method for detecting Acanthopanax senticosus and Glycyrrhiza uralensis preparation and application thereof | |
CN114099574B (en) | Extraction method of coptis chinensis extract for reducing blood glucose and extract thereof | |
CN108508112B (en) | Method for detecting content of triptolide A and triptolide B in celastrus orbiculatus | |
CN103239435B (en) | Preparation method of gynura divaricata total caffeoylquinic acid and application in antihyperglycemic agent or health-care product | |
CN1981790B (en) | Rhizoma Chuanxiong effective components and production thereof | |
CN114634535A (en) | Separation and purification method of anoectochilus formosanus glycoside and application of anoectochilus formosanus glycoside in soothing cosmetics | |
CN1981822B (en) | Tree-peony root bark effective component, its preparation, making method and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |